You are here:

1. Homepage
2. Pharmacovigilance
3. Information on Risks

Information Letter on Exelon® and Prometax® transdermal patches (active substance: rivastigmine): incorrect administration and medication error

In association with the rivastigmine transdermal patches, Exelon^® and Prometax^®, cases of overdosage due to medication errors and incorrect administration have been reported. An  Information Letter on Exelon® and Prometax® (file size: 97 KB) (available in german only) will be circulated.